PEG
55
2
JNJ
35
5
DG
12
-2
DVN
24
2
EL
27
2
WMB
60
2
WY
36
5
ABBV
46
4
OXY
34
-8
CNP
52
-7
WU
24
-2
PFG
30
3
JCI
42
-2
MA
62
2
CVX
14
-11
DVA
65
3
NAVI
33
-8
CCL
64
-6
WFC
60
2
CI
38
3
PEG
55
2
JNJ
35
5
DG
12
-2
DVN
24
2
EL
27
2
WMB
60
2
WY
36
5
ABBV
46
4
OXY
34
-8
CNP
52
-7
WU
24
-2
PFG
30
3
JCI
42
-2
MA
62
2
CVX
14
-11
DVA
65
3
NAVI
33
-8
CCL
64
-6
WFC
60
2
CI
38
3
Financhill
Back

Pathward Financial Vs. Novo Nordisk AS Industry Stock Comparison

Sell
44

CASH
Pathward Financial

Last Price:
$74.82
Seasonality Move:
5.4%
Sell
26

NVO
Novo Nordisk AS

Last Price:
$87.33
Seasonality Move:
6.58%
Sell
44
Pathward Financial (CASH) is a Sell

Is Pathward Financial a Buy, Sell or Hold?

  • The current Pathward Financial [CASH] share price is $74.08. The Score for CASH is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • CASH is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
26
Novo Nordisk AS (NVO) is a Sell

Is Novo Nordisk AS a Buy, Sell or Hold?

  • The current Novo Nordisk AS [NVO] share price is $88.71. The Score for NVO is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
  • NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CASH Stock Price Chart

What is Pathward Financial's stock price today?

  • The Pathward Financial share price today is $74.08
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CASH is experiencing buying pressure, which is a positive indicator for future bullish movement.

NVO Stock Price Chart

What is Novo Nordisk AS's stock price today?

  • The Novo Nordisk AS share price today is $88.71
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing buying pressure, which is a positive indicator for future bullish movement.

CASH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.92 Sell
Relative Strength Index (14 RSI): 33.77 Sell
Chaikin Money Flow: 91887 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (77.69 - 84.49) Sell
Bollinger Bands (100): (64.48 - 79) Buy

NVO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.52 Sell
Relative Strength Index (14 RSI): 27.28 Sell
Chaikin Money Flow: 14079249 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (99.16 - 111.42) Sell
Bollinger Bands (100): (106.53 - 131.27) Sell

CASH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 77.86 Sell
20-day SMA: 81.29 Sell
50-day SMA: 77.86 Sell
200-day SMA: 62.99 Buy
8-day EMA: 77 Sell
20-day EMA: 79.17 Sell
50-day EMA: 77.3 Sell
200-day EMA: 66.11 Buy

NVO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 101.84 Sell
20-day SMA: 105.84 Sell
50-day SMA: 108.65 Sell
200-day SMA: 126.03 Sell
8-day EMA: 99.1 Sell
20-day EMA: 103.93 Sell
50-day EMA: 109.19 Sell
200-day EMA: 117.8 Sell

Pathward Financial Earnings Growth & CASH Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.33 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.60 per share, and an increase next year of $0.81 per share.

Novo Nordisk AS Earnings Growth & NVO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.49 per share, and an increase next year of $0.66 per share.

Pathward Financial Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novo Nordisk AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):